Provider-guided programs
What happens in a peptide therapy consultation?
A legitimate consultation reviews your medical history, current medications, contraindications, and goals; orders labs when indicated; and gives you a realistic, evidence-graded picture — including the option of no therapy. It is a medical evaluation, not a sales call, and it can end in "not appropriate."
What the provider reviews
- Full medical and medication history
- Contraindications: malignancy history, pregnancy, endocrine and metabolic conditions
- Prior therapies and outcomes
- Baseline labs when clinically indicated
Questions worth asking
- What human evidence supports this for my goal?
- Is this compounded or FDA-approved, and what does that change?
- What monitoring and follow-up will I need?
- What happens when I stop?
- What are the alternatives, including doing nothing?
Red flags
Guaranteed prescriptions, dose menus published before any history review, pressure to bundle medication with membership, and reluctance to name the prescribing provider or pharmacy are all reasons to walk away.
References
- US Food and Drug Administration (2024). FDA's concerns with unapproved GLP-1 drugs used for weight loss. FDA Drug Alerts and Statements. SourceAgency notice
- US Food and Drug Administration (2023). Certain bulk drug substances for use in compounding that may present significant safety risks. FDA Human Drug Compounding. SourceAgency notice
- US Food and Drug Administration (2023). Human drug compounding: compounded drugs are not FDA-approved. FDA. SourceAgency guidance
Found an error? Report a correction.